NIH Director Ignores Proposed Funding Based On HHS Goals In Budget Request
This article was originally published in The Tan Sheet
Francis Collins tells a House Appropriations subcommittee that a proposed decrease in NIH funding going toward “advancing scientific knowledge and innovation” will not affect how grants and research dollars are allocated.
You may also be interested in...
A 2014 omnibus appropriations bill agreed to by Senate and House appropriators would give FDA $2.55 billion in discretionary funding, a $91 million increase. In news applauded by the device industry, the bill would also make available $85 million in previously sequestered FDA user fees.
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.
FDA Commissioner Robert Califf says mentioning China helps increase congressional support.